Investors bet on AI drug discovery despite approval gap

US specialist venture firm Dimension Capital raises $800mn fund to back AI-designed medicines

📰 Original Source

This article was originally published on Financial Times – AI. Click below to read the complete article.

Read Full Article on Financial Times – AI →